Clover Health projects FY 2026 revenue between $2.92 billion and $3.0 billion, citing a 4.5-star rating for growth flexibility.
Clover Health Investments Corp. (CLOV) outlined a Q2 2026 revenue target of $2.92 billion to $3.0 billion during its earnings call. The company attributed the outlook to a 4.5-star quality rating, which enhances flexibility for 2027 growth strategies.
Management highlighted AI-driven tools aimed at improving physician decision-making at the point of care. The focus on technology and member outcomes is expected to drive better care and sustained revenue growth.
No immediate market reaction was detailed in the source, but the guidance reflects confidence in operational improvements and regulatory tailwinds.